Varenicline Nitrogen Oxide
- Molecular Weight: 0
- Update Date: 2023-04-23 13:52:06
What is Varenicline Nitrogen Oxide?
The Uses of Varenicline Nitrogen Oxide
Varenicline Nitrogen Oxide is a derivative of Varenicline (V215635(M)), which is a useful medication for smoking cessation.
Properties of Varenicline Nitrogen Oxide
| Melting point: | >169°C (dec.) |
| storage temp. | -20°C Freezer |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Solid |
| color | Pale Yellow |
Safety information for Varenicline Nitrogen Oxide
Computed Descriptors for Varenicline Nitrogen Oxide
New Products
6-Hydroxy-2,4-Diaminopyrimidine 2,6-Dipicolic Acid 3-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID 4-Fluorophenylglycine 1-N-Boc-3-(aminoethyl)azetidine Dimedone 1-Boc-3-(cyanomethyl)azetidine N-BOC-piperidine-4-carboxylic acid 3-Hydroxypyridine 2-Bromo-5-Chloro-3-Nitropyridine 2-Amino-3-Nitro-5-Chloro Pyridine 2-Amino-5-Iodopyridine 5-Amino-2-Hydroxypyridine 2,5-Dibromopyridine 2-BROMOACETYL BROMIDE-D2 METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR BENZENE-D6 TOLUENE-D3 5-Acetylsalicylamide 1-(3-Chlorophenyl)-4-(3-Chloropropyl) piperazine hydrochloride 4-(Methyl amino)-3-Nitro benzoic acid 3,4,5-Trimethoxy benzoic acidYou may like
-
67914-85-6 cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol (IT8)View Details
67914-85-6 -
350-03-8 3-AcetylpyridineView Details
350-03-8 -
6-Chloro-2,4-Diamino pyrimidine 156-83-2View Details
156-83-2 -
1-(4-Aminophenyl)-4-(4-methoxyphenyl)Piperazine 74852-62-3View Details
74852-62-3 -
556-08-1 4-Acetamidobenzoic acidView Details
556-08-1 -
61397-56-6View Details
61397-56-6 -
5-Bromo-2-Chlorobenzoic acid 21739-92-4View Details
21739-92-4 -
15128-52-6View Details
15128-52-6
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
